---
title: 'Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic
  Consequences, Treatment Patterns, and Outcomes in the Modern Management Era'
date: '2024-04-12'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38606558/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240412180741&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Our data display heterogeneity within the group of vasoresponders,
  with a large subset failing to show a sustained satisfactory clinical response to
  CCBs. This highlights the necessity for comprehensive reassessment during early
  follow-up. The use of pulmonary artery compliance in addition to current measures
  may better identify those likely to have a good long-term ...'
disable_comments: true
---
CONCLUSIONS: Our data display heterogeneity within the group of vasoresponders, with a large subset failing to show a sustained satisfactory clinical response to CCBs. This highlights the necessity for comprehensive reassessment during early follow-up. The use of pulmonary artery compliance in addition to current measures may better identify those likely to have a good long-term ...